Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep

Vaccine

Volumn 27, Issue 11, 2009, Pages 1741-1749

  Barrio, María B ^a   Grilló, María J ^b   Muñoz, Pilar M ^c   Jacques, Isabelle ^a,d   González, David ^e   de Miguel, María J ^c   Marín, Clara M ^c   Barberán, Montserrat ^f   Letesson, Jean J ^g   Gorvel, Jean P ^h,i,j   Moriyón, Ignacio ^e   Blasco, José M ^c   Zygmunt, Michel S ^a  

^a UR1282   (France)

^b CSIC   (Spain)

^c Instituto Agroalimentario de Aragón IA2   (Spain)

^d Institut Universitaire de Technologie   (France)

^e UNIVERSITY OF NAVARRA   (Spain)

^f UNIVERSIDAD DE ZARAGOZA   (Spain)

^g UNIVERSITY OF NAMUR   (Belgium)

^h CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

ⁱ INSERM   (France)

^j CNRS   (France)

more..

Author keywords

Brucellosis; Lipopolysaccharide; Rough mutant; Sheep; Vaccine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BRUCELLA VACCINE; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIUM MUTANT; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; SHEEP; SKIN BIOPSY; VACCINE PRODUCTION;

EID: 61349185036     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.025     Document Type: Article

References (51)

1. Seimenis A., Morelli D., and Mantovani A. Zoonoses in the Mediterranean region. Ann Ist Super Sanita 42 4 (2006) 437-445
2. Pappas G., Papadimitriou P., Akritidis N., Christou L., and Tsianos E.V. The new global map of human brucellosis. Lancet Infect Dis 6 2 (2006) 91-99
3. Benkirane A. Ovine and caprine brucellosis: world distribution and control/eradication strategies in West Asia/North Africa region. Small Rumin Res 62 1-2 (2006) 19-25
4. Animal brucellosis. In: Alton G.G., Nielsen K.H., and Duncan J.R. (Eds). Brucella melitensis, vol. 17 (1990), CRC Press, Boca Raton 383-409
5. Blasco J.M. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 31 3-4 (1997) 275-283
6. Garin-Bastuji B., Blasco J.M., Grayon M., and Verger J.M. Brucella melitensis infection in sheep: present and future. Vet Res 29 3-4 (1998) 255-274
7. Ariza J., Bosilkovski M., Cascio A., Colmenero J.D., Corbel M.J., Falagas M.E., et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4 12 (2007) 1872-1878
8. Moriyón I., Grilló M.J., Monreal D., González D., Marín C., López-Goñi I., et al. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35 1 (2004) 1-38
9. Schurig G.G., Sriranganathan N., and Corbel M.J. Brucellosis vaccines: past, present and future. Vet Microbiol 90 1-4 (2002) 479-496
10. El-Idrissi A.H., Benkirane A., El-Maadoudi M., Bouslikhane M., Berrada J., and Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech Off Int Epizoot 20 3 (2001) 741-747
11. Villarroel M., Grell M., and Saenz R. Isolation and identification of Brucella abortus RB51 in human: first report in Chile. Arch Med Vet 32 1 (2000) 89-91
12. Cloeckaert A., Vizcaíno N., Paquet J.Y., Bowden R.A., and Elzer P.H. Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol 90 1-4 (2002) 229-247
13. Spink W.W. The nature of brucellosis. The pathogenesis of brucellosis, vol. 6 (1956), The University of Minnesota Press, Minneapolis p. 113-44
14. Winter A.J., Schurig G.G., Boyle S.M., Sriranganathan N., Bevins J.S., Enright F.M., et al. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am J Vet Res 57 5 (1996) 677-683
15. Elzer P.H., Enright F.M., McQuiston J.R., Boyle S.M., and Schurig G.G. Evaluation of a rough mutant of Brucella melitensis in pregnant goats. Res Vet Sci 64 3 (1998) 259-260
16. Monreal D., Grilló M.J., González D., Marín C.M., De Miguel M.J., López-Goñi I., et al. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect Immun 71 6 (2003) 3261-3271
17. Grilló M.J., Manterola L., de Miguel M.J., Muñoz P.M., Blasco J.M., Moriyón I., et al. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Vaccine 24 15 (2006) 2910-2916
18. González D., Grilló M.J., De Miguel M., Ali T., Arce-Gorvel V., Delrue RM, et al. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS ONE 3 July (7) (2008) e2760
19. Alton G.G., Jones L.M., Angus R.D., and Verger J.M. Techniques for the brucellosis laboratory (1988), INRA, Paris, France
20. Blasco J.M., Garin-Bastuji B., Marín C.M., Gerbier G., Fanlo J., Jiménez de Bagüés M.P., et al. Efficacy of different rose bengal and complement fixation antigens for the diagnosis of Brucella melitensis infection in sheep and goats. Vet Rec 134 16 (1994) 415-420
21. Manual for diagnostic tests and vaccines for terrestrial animals. Caprine and ovine brucellosis (excluding Brucella ovis) (2004), O.I.E. [chapter 2.4.2]
22. Alonso-Urmeneta B., Marín C.M., Aragón V., Blasco J.M., Díaz R., and Moriyón I. Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle. Clin Diagn Lab Immunol 5 6 (1998) 749-754
23. Galanos C., Luderitz O., and Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem 9 2 (1969) 245-249
24. Marín C.M., Alonso-Urmeneta B., Moriyón I., Pérez-Gómez S., and Blasco J.M. Comparison of polyclonal, monoclonal and protein G peroxidase conjugates in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis in sheep. Vet Rec 143 14 (1998) 390-394
25. Ficapal A., Alonso-Urmeneta B., Velasco J., Moriyón I., and Blasco J.M. Diagnosis of Brucella ovis infection of rams with an ELISA using protein G as conjugate. Vet Rec 137 6 (1995) 145-147
26. Marín C.M., Jiménez de Bagüés M.P., Barberán M., and Blasco J.M. Comparison of two selective media for the isolation of Brucella melitensis from naturally infected sheep and goats. Vet Rec 138 17 (1996) 409-411
27. Verger J.M., Grayon M., Zundel E., Lechopier P., and Olivier-Bernardin V. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes. Vaccine 13 2 (1995) 191-196
28. Jones L.M., Entessar F., and Ardalan A. Comparison of living and non living vaccines in producing immunity against natural Brucella melitensis infection in sheep and goats in Iran. J Comp Pathol 74 (1964) 17-30
29. Cloeckaert A., Jacques I., Grilló M.J., Marín C.M., Grayon M., Blasco J.M., et al. Development and evaluation as vaccines in mice of Brucella melitensis Rev. 1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Vaccine 22 21-22 (2004) 2827-2835
30. Jiménez de Bagüés M.P., Elzer P.H., Blasco J.M., Marín C.M., Gamazo C., and Winter A.J. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect Immun 62 2 (1994) 632-638
31. Adams L.G., Ficht T.A., and Allen C.A. Derivation and evaluation of the rough rfbk brucellosis vaccine in cattle. In: Anon. (Ed). Memorias del III Foro Nacional de Brucelosis. Acapulco, México, 20-21 July 1998 (1999) 141-158
32. Leonard S., Ferooz J., Haine V., Danese I., Fretin D., Tibor A., et al. FtcR is a new master regulator of the flagellar system of Brucella melitensis 16M with homologs in Rhizobiaceae. J Bacteriol 189 1 (2007) 131-141
33. Rajashekara G., Glover D.A., Krepps M., and Splitter G.A. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell Microbiol 7 10 (2005) 1459-1473
34. Zygmunt M.S., Hagius S.D., Walker J.V., and Elzer P.H. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host. Microb Infect 8 14-15 (2006) 2849-2854
35. Kahl-McDonagh M.M., Elzer P.H., Hagius S.D., Walker J.V., Perry Q.L., Seabury C.M., et al. valuation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine 24 24 (2006) 5169-5177
36. Elzer P.H., Enright F.M., McQuiston J.R., Boyle S.M., and Schurig G.G. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine 24 24 (2006) 5169-5177
37. Jiménez de Bagüés M.P., Barberán M., Marín C.M., and Blasco J.M. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine 13 3 (1995) 301-304
38. Gorvel J.P., and Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 90 1-4 (2002) 281-297
39. Arellano-Reynoso B., Díaz-Aparicio E., Leal-Hernández M., Hernández L., and Gorvel J.P. Intracellular trafficking study of a RB51 B. abortus vaccinal strain isolated from cow milk. Vet Microbiol 98 3-4 (2004) 307-312
40. Fernández-Prada C.M., Zelazowska E.B., Nikolich M., Hadfield T.L., Roop II R.M., Robertson G.L., et al. Interactions between Brucella melitensis and human phagocytes: bacterial surface O-polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis. Infect Immun 71 4 (2003) 2110-2119
41. Billard E., Cazevieille C., Dornand J., and Gross A. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect Immun 73 12 (2005) 8418-8424
42. Billard E., Dornand J., and Gross A. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect Immun (2007)
43. Salcedo S.P., Marchesini M.I., Lelouard H., Fugier E., Jolly G., Balor S., et al. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog 4 2 (2008) e21
44. Allen C.A., Adams L.G., and Ficht T.A. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect Immun 66 3 (1998) 1008-1016
45. Foulongne V., Bourg G., Cazevieille C., Michaux-Charachon S., and O'Callaghan D. Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis. Infect Immun 68 3 (2000) 1297-1303
46. Araya L.N., and Winter A.J. Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun 58 1 (1990) 254-256
47. Montaraz J.A., Winter A.J., Hunter D.M., Sowa B.A., Wu A.M., and Adams L.G. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect Immun 51 3 (1986) 961-963
48. Plommet M., Hue I., and Plommet A.M. L'immunite anti-Brucella transferee par serum immun et l'immunite transferee par les lymphocytes spleniques ne s'additionnent pas. Ann Rech Vet 17 2 (1986) 169-175
49. Limet J.N., Plommet A.M., Dubray G., and Plommet M. Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis. Ann Inst Pasteur/Immunol 138 (1987) 417-424
50. Cunningham B. Protective effects of calostral antibodies to B. abortus on strain 19 vaccination and field injection. Vet Rec 101 26-27 (1977) 521-524
51. Mainar-Jaime RC, Marín CM, De Miguel MJ, Muñoz PM, Blasco JM. Experiences on the use of RB51 vaccine in Spain. Proceedings of the Brucellosis 2008 International Conference, Royal Holloway College, University of London, UK, 10-13 September 2008, p. 40.